Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene AlterationWassim Abida, Cora N. Sternberg, Simon P. Watkins et al.|Journal of Clinical Oncology|2020Cited by 676
Pan-cancer image-based detection of clinically actionable genetic alterationsJakob Nikolas Kather, Tom Luedde, Lara R. Heij et al.|Nature Cancer|2020Cited by 630
Reversal of Lactate and PD-1–mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate CancerKiranj Chaudagar, Akash Patnaik|Clinical Cancer Research|2023Cited by 122
A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancerElena Garralda, Gerald S. Falchook, Ammar Sukari et al.|ESMO Open|2022Cited by 87
Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage PhagocytosisKiranj Chaudagar, Akash Patnaik|Clinical Cancer Research|2023Cited by 54